Bausch + Lomb: Profits Return In Q3 As A Recovery Story, While Pipeline GrowsSeeking Alpha • 11/06/26
Are You Looking for a Top Momentum Pick? Why Bausch + Lomb (BLCO) is a Great ChoiceZacks Investment Research • 11/05/26
Why Bausch + Lomb (BLCO) is a Top Momentum Stock for the Long-TermZacks Investment Research • 11/04/26
Bausch + Lomb Announces Publication of Multinational Survey Results Highlighting the Burden of Dry Eye Symptoms and Opportunities for Improved Awareness and Patient EducationBusiness Wire • 10/29/26
Bausch + Lomb Posts Strong Third-Quarter Performance, Raises Full-Year 2026 GuidanceBusiness Wire • 10/28/26
Bausch + Lomb and Bausch Health Announce Appointment of Thomas J. Appio as Interim Bausch + Lomb CEO, Expect to Raise Full-Year 2026 GuidanceBusiness Wire • 10/12/26
Bausch + Lomb Advances Novel Oral Treatment for Dry AMD Following Constructive FDA MeetingBusiness Wire • 10/06/26
BLCO Gains European CE Mark for Next-Gen SeeLyra Femtosecond LaserZacks Investment Research • 09/14/26
Bausch + Lomb Announces European CE Mark Approval of SeeLyra™ Femtosecond LaserBusiness Wire • 09/11/26
Bausch + Lomb Announces New Published Research on enVista Aspire™ Real World ExperienceBusiness Wire • 09/02/26